Plunkett Research Online: WuXi Biologics (Cayman)

WUXI BIOLOGICS (CAYMAN) (WXXWY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

WuXi Biologics (“WuXi”) is a contract development and manufacturing organization, or “CDMO,” for biologic drugs. It was founded in 2010 as part of WuXi AppTec and listed on the Hong Kong Stock Exchange in 2017. WuXi provides comprehensive services from conception to commercialization, including drug.....



WuXi Biologics (Cayman)
Ticker: WXXWY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone:
Fax:
Address: No. 108, Meiliang Road
Mashan Binhu District
Wuxi, 214092 China

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description
Chen ZhishengCEO/Director
Li GeChairman of the Board/Director
See More
WuXi Biologics (“WuXi”) is a contract development and manufacturing organization, or “CDMO,” for biologic drugs. It was founded in 2010 as part of WuXi AppTec and listed on the Hong Kong Stock Exchange in 2017. WuXi provides comprehensive services from conception to commercialization, including drug.....See More See More

Auditor: Deloitte Touche Tohmatsu
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: